101 related articles for article (PubMed ID: 4951982)
41. Movement disorders in patients treated with long-acting injectable antipsychotic drugs.
Bransgrove LL; Kelly MW
Am J Hosp Pharm; 1994 Apr; 51(7):895-9. PubMed ID: 7912473
[TBL] [Abstract][Full Text] [Related]
42. [Long-acting injectable risperidone: naturalistic study in three hospitals in Aquitaine].
Raignoux C; Dusouchet T; Bret P; Queuille E; Biscay ML; Caron J; Bret MC
Encephale; 2007 Dec; 33(6):973-81. PubMed ID: 18789790
[TBL] [Abstract][Full Text] [Related]
43. [Clinical experience with fluphenazine decanoate in psychoses].
Náhunek K; Rodová A; Svestka J
Act Nerv Super (Praha); 1970 Jan; 12(1):47-9. PubMed ID: 5460564
[No Abstract] [Full Text] [Related]
44. Patients in the early phases of schizophrenia and schizoaffective disorders effectively treated with risperidone long-acting injectable.
Parellada E; Andrezina R; Milanova V; Glue P; Masiak M; Turner MS; Medori R; Gaebel W
J Psychopharmacol; 2005 Sep; 19(5 Suppl):5-14. PubMed ID: 16144781
[TBL] [Abstract][Full Text] [Related]
45. [Clinical experience with fluphenazine Depot].
Vencovský E; Sedivec V; Peterová E; Baudis P; Dvoráková M
Act Nerv Super (Praha); 1970 Jan; 12(1):49-50. PubMed ID: 5418656
[No Abstract] [Full Text] [Related]
46. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
47. Long-term safety and efficacy of long-acting risperidone in elderly psychotic patients.
Kissling W; Glue P; Medori R; Simpson S
Hum Psychopharmacol; 2007 Dec; 22(8):505-13. PubMed ID: 17902187
[TBL] [Abstract][Full Text] [Related]
48. [Action of fluphenazine and benzperidol on psychologic tests (Rorschach) of psychotic patients].
Haumonte MT; Wurtz D; Brenet ; Jacquot MP
Ann Med Psychol (Paris); 1970 Jan; 1(1):121-34. PubMed ID: 5421305
[No Abstract] [Full Text] [Related]
49. Efficacy and safety of long-acting risperidone in elderly patients with schizophrenia and schizoaffective disorder.
Lasser RA; Bossie CA; Zhu Y; Gharabawi G; Eerdekens M; Davidson M
Int J Geriatr Psychiatry; 2004 Sep; 19(9):898-905. PubMed ID: 15352149
[TBL] [Abstract][Full Text] [Related]
50. Double-blind study of tybamate in psychotic patients.
Meshel E; Denber HC
Dis Nerv Syst; 1967 May; 28(5):311-3. PubMed ID: 5338174
[No Abstract] [Full Text] [Related]
51. [Dibenzoxazepines in psychotic patients].
García PR; Millán S; Méndez H
Neurol Neurocir Psiquiatr; 1970; 11(1):41-56. PubMed ID: 5527967
[No Abstract] [Full Text] [Related]
52. The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders.
Mamo DC; Sweet RA; Chengappa KN; Reddy RR; Jeste DV
Int J Geriatr Psychiatry; 2002 Nov; 17(11):1012-7. PubMed ID: 12404650
[TBL] [Abstract][Full Text] [Related]
53. Efficacy and safety of long-acting risperidone in stable patients with schizoaffective disorder.
Lasser R; Bossie CA; Gharabawi G; Eerdekens M; Nasrallah HA
J Affect Disord; 2004 Dec; 83(2-3):263-75. PubMed ID: 15555724
[TBL] [Abstract][Full Text] [Related]
54. Clinical and ergotherapeutic evaluation of fluspirilene (R 6218), a long-acting injectable neuroleptic, in chronic psychotic patients.
Tanghe A; Vereecken JL
Psychiatr Neurol Neurochir; 1971; 74(5):379-89. PubMed ID: 5138128
[No Abstract] [Full Text] [Related]
55. [Management of psychotic drive disorders].
Langner E
Wien Med Wochenschr; 1968 Sep; 118(36):700-2. PubMed ID: 5679053
[No Abstract] [Full Text] [Related]
56. [Results of treatment by Moditen Depot in outpatients' wards in the South Moravian Region (author's transl)].
Rektor L; Blazek J
Cesk Psychiatr; 1980; 76(6):369-75. PubMed ID: 7471277
[No Abstract] [Full Text] [Related]
57. [Delayed-action preparation therapy as a possibility in social rehabilitation].
Haring C
Med Welt; 1972 Aug; 23(35):1140-3. PubMed ID: 5075530
[No Abstract] [Full Text] [Related]
58. The use of long-acting neuroleptics in the acute psychoses.
Cassano GB; Placidi GF
Acta Psychiatr Belg; 1981; 81(2):173-81. PubMed ID: 6117187
[TBL] [Abstract][Full Text] [Related]
59. [Treatment of schizophrenic psychoses by sustained-action neuroleptics in psychiatric outpatients' treatment (author's transl)].
Polácek J
Cesk Psychiatr; 1982 Feb; 78(1):49-55. PubMed ID: 7060182
[No Abstract] [Full Text] [Related]
60. Fluphenazine treatment in the psychotic child: clinical-evoked potential correlations.
Saletu B; Saletu M; Simeon J; Marasa J
Compr Psychiatry; 1975; 16(3):265-78. PubMed ID: 1139924
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
